Skip to main content

Advertisement

Log in

Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Objects

We aim to evaluate the characteristics of pediatric patients with neurofibromatosis type 1 (NF1) who developed soft tissue sarcomas (STSs) and central nervous system (CNS) tumors that have been followed up in our center.

Materials and methods

Medical records of children with NF1 were retrospectively analyzed.

Results

There were 78 patients who met at least two diagnostic criteria for NF1. The median age of patients was 10 years (0.5–18), and M/F ratio was 1.3. The prevalance of the optic glioma was 11.5% (n = 9), and one patient with optic glioma also had cystic astrocytoma, one patient had brain stem tumor, and one patient had a CNS tumor (without histopathologic diagnosis). Seven of nine children were ≥7 years old at the time of the diagnosis of optic glioma. Visual impairment developed in four patients, and two of them were treated with radiotherapy solely on the basis of evidence of clinical and radiological progression of the tumors. Four patients developed STSs. Two of them had malignant peripheral nerve sheath tumors (MPNST), and the remaining two had bladder rhabdomyosarcoma. Three of the four patients with STSs died with progressive disease.

Conclusion

The clinical course of malignancy in NF1 is often different from that of similar tumor types in the general population. Careful follow-up in patients with NF1 is required to enable the early diagnosis of malignancies, and the developments of new targeted therapies are needed for improvement of the outcome for patients of this group, especially with MPNST.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bader JL, Miller RW (1978) Neurofibromatosis and childhood leukemia. J Pediatr 92:925–929

    Article  PubMed  CAS  Google Scholar 

  2. Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet A 127A:224–229

    Article  PubMed  CAS  Google Scholar 

  3. Brems H, Beert E, de Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10:508–515

    Article  PubMed  CAS  Google Scholar 

  4. Brodeur GM (1994) The NF1 gene in myelopoiesis and childhood myelodysplastic syndromes. N Engl J Med 330:637–639

    Article  PubMed  CAS  Google Scholar 

  5. Brzowski AE, Bazan C III, Mumma JV, Ryan SG (1992) Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 42:679–681

    PubMed  CAS  Google Scholar 

  6. Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, Cecchetto G, Alaggio R, De SL, Koscielniak E, Sotti G, Treuner J (2005) Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol 23:8422–8430

    Article  PubMed  Google Scholar 

  7. Coffin CM, Cassity J, Viskochil D, Randall RL, Albritton K (2004) Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Med Genet A 127A:40–43

    Article  PubMed  Google Scholar 

  8. De RT, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288–1292

    Article  Google Scholar 

  9. Distelmaier F, Fahsold R, Reifenberger G, Messing-Juenger M, Schaper J, Schneider DT, Gobel U, Mayatepek E, Rosenbaum T (2007) Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up. Childs Nerv Syst 23:343–347

    Article  PubMed  Google Scholar 

  10. Doorn PF, Molenaar WM, Buter J, Hoekstra HJ (1995) Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 21:78–82

    Article  PubMed  CAS  Google Scholar 

  11. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006–2021

    Article  PubMed  CAS  Google Scholar 

  12. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314

    Article  PubMed  CAS  Google Scholar 

  13. Ferrari A, Bisogno G, Carli M (2007) Management of childhood malignant peripheral nerve sheath tumor. Paediatr Drugs 9:239–248

    Article  PubMed  Google Scholar 

  14. Friedrich RE, Hartmann M, Mautner VF (2007) Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children. Anticancer Res 27:1957–1960

    PubMed  CAS  Google Scholar 

  15. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57

    Article  PubMed  CAS  Google Scholar 

  16. Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova LC, Irons MB, Ullrich NJ (2010) Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer 54:890–896

    PubMed  Google Scholar 

  17. King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93:388–392

    Article  PubMed  CAS  Google Scholar 

  18. Koszyca B, Moore L, Byard RW (1993) Lethal manifestations of neurofibromatosis type 1 in childhood. Pediatr Pathol 13:573–581

    Article  PubMed  CAS  Google Scholar 

  19. Listernick R, Charrow J (1990) Neurofibromatosis type 1 in childhood. J Pediatr 116:845–853

    Article  PubMed  CAS  Google Scholar 

  20. Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63–66

    Article  PubMed  CAS  Google Scholar 

  21. Listernick R, Charrow J, Greenwald MJ, Esterly NB (1989) Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114:788–792

    Article  PubMed  CAS  Google Scholar 

  22. Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198

    Article  PubMed  CAS  Google Scholar 

  23. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J (2004) Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63:1944–1946

    PubMed  CAS  Google Scholar 

  24. Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41:143–149

    Article  PubMed  CAS  Google Scholar 

  25. Maria BL, Menkes JH (2006) Neurocutaneous syndromes. In: Menkes JH, Sarnat HB, Maria BL (eds) Chid neurology. Lippincott Williams & Wilkins, Philadelphia, pp 803–828

    Google Scholar 

  26. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J (1993) Neurofibromatosis type 1 and childhood cancer. Cancer 72:2746–2754

    Article  PubMed  CAS  Google Scholar 

  27. O’Marcaigh AS, Shannon KM (1997) Role of the NF1 gene in leukemogenesis and myeloid growth control. J Pediatr Hematol Oncol 19:551–554

    Article  PubMed  Google Scholar 

  28. Oguzkan S, Terzi YK, Guler E, Derbent M, Agras PI, Saatci U, Ayter S (2006) Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene. Cancer Genet Cytogenet 164:159–163

    Article  PubMed  CAS  Google Scholar 

  29. Onal C, Bayindir C (1999) Gliomatosis cerebri with neurofibromatosis: an autopsy-proven case. Childs Nerv Syst 15:219–221

    Article  PubMed  CAS  Google Scholar 

  30. Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, Murgia A (1999) Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 14:352–356

    Article  PubMed  CAS  Google Scholar 

  31. Piccirilli M, Lenzi J, Delfinis C, Trasimeni G, Salvati M, Raco A (2006) Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature. Childs Nerv Syst 22:1332–1337

    Article  PubMed  Google Scholar 

  32. Plon SE, Malkin D (2006) Childhood cancer and heredity. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott-Roven, Philedelphia, pp 14–37

    Google Scholar 

  33. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM (2003) Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111:777–784

    Article  PubMed  Google Scholar 

  34. Reich S, Overberg-Schmidt US, Leenen A, Henze G (1999) Neurofibromatosis 1 associated with embryonal rhabdomyosarcoma of the urinary bladder. Pediatr Hematol Oncol 16:263–266

    Article  PubMed  CAS  Google Scholar 

  35. Segal L, Rvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC (2010) Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. J AAPOS 14:155–158

    Article  PubMed  Google Scholar 

  36. Shearer P, Parham D, Kovnar E, Kun L, Rao B, Lobe T, Pratt C (1994) Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 22:78–83

    Article  PubMed  CAS  Google Scholar 

  37. Sorensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314:1010–1015

    Article  PubMed  CAS  Google Scholar 

  38. Sung L, Anderson JR, Arndt C, Raney RB, Meyer WH, Pappo AS (2004) Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV. J Pediatr 144:666–668

    Article  PubMed  Google Scholar 

  39. Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM (2000) Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 19:429–439

    Article  PubMed  CAS  Google Scholar 

  40. Uyttebroeck A, Legius E, Brock P, Van de CW, Casaer P, Casteels-Van DM (1995) Consecutive glioblastoma and B cell non-Hodgkin’s lymphoma in a young child with von Recklinghausen’s neurofibromatosis. Med Pediatr Oncol 24:46–49

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of ınterest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emre Cecen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cecen, E., Ince, D., Uysal, K.M. et al. Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1. Childs Nerv Syst 27, 1885–1893 (2011). https://doi.org/10.1007/s00381-011-1425-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-011-1425-x

Keywords

Navigation